S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Alma North America Brings Korean Skin-Quality Protocol to States

As North American aesthetic trends shift from radical transformation to long-term preventative care, Alma North America has introduced TitaniumLift™. This new 20-minute protocol, derived from popular Korean methodologies, utilizes the existing Soprano Titanium® platform to deliver multi-depth thermal energy while maintaining skin health through continuous cooling technology.

Alma North America Brings Korean Skin-Quality Protocol to States
Photo: Bio & News

The protocol integrates triple-wavelength technology—755nm, 810nm, and 1064nm—to treat various dermal layers simultaneously. By focusing on deep dermal heating rather than surface-level correction, the treatment aligns with a growing consumer preference for consistent, low-downtime maintenance. Industry data underscores this pivot, with 73% of patients now favoring preventative aesthetic procedures over traditional restorative surgeries.

Nurse Jamie, a prominent aesthetic expert, noted that the Korean approach prioritizes comprehensive structural support rather than targeting isolated layers of the skin. Designed for all Fitzpatrick skin types (I-VI), the procedure is recommended on a monthly basis. This launch arrives as the global K-Beauty market continues its rapid expansion, with projections estimating the sector will reach approximately $129 billion this year, with North America accounting for roughly 34% of that total.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!